New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Halcon Resources Corp (NYSE:HK), Camtek LTD (NASDAQ:CAMT), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), Rentech, Inc (NASDAQ:RTK)
Halcon Resources Corp (NYSE:HK) showed a volume of 4.22 million shares by the end of last trade whereas the average volume of the stock remained 5.69 million shares. The stock opened the session at $3.89 but then moved to $3.88. At that price, the stock showed a negative performance of -0.51%. Halcon Resources Corporation (Halcon Resources) is an independent energy company focused on the acquisition, production, exploration and development of onshore liquids-rich oil and natural gas assets in the United States. The Company has oil and natural gas reserves located primarily in Texas, North Dakota, Louisiana, Oklahoma and Montana. On August 1, 2012, the Company acquired GeoResources by merger.
Will HK Get Buyers Even After The Recent Rally? Find Out Here
Camtek LTD (NASDAQ:CAMT) opened the session at $3.83 and closed the session at $4.40. The stock showed a positive performance of 10.62% in previous trading session. Traded with volume of 2.95 million shares in the prior session and the average volume of the stock remained 3.65 million shares. Camtek Ltd. (Camtek) designs, develops, manufactures and markets automated solutions dedicated for enhancing production processes and yield for the semiconductor manufacturing and packaging and the printed circuit board (PCB) and integrated circuit (IC) substrate industries. Camtek also designs, develops, manufactures and markets automated optical inspection (AOI), systems and related products.
For How Long CAMT will fight for Profitability? Read This Trend Analysis report
Chelsea Therapeutics International Ltd (NASDAQ:CHTP) opened the session at $4.19 and closed the session at $4.40. The stock showed a positive performance of 6.54% in previous trading session. Traded with volume of 2.48 million shares in the prior session and the average volume of the stock remained 1.73 million shares. The beta of the stock remained 1.36. Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson’s Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia,
Why Should Investors Buy CHTP After The Recent Gain? Just Go Here and Find Out
Rentech, Inc (NASDAQ:RTK) the stock decreased -1.47% and finished the session at $1.68. Traded with volume of 2.12 million shares in the prior session and the average volume of the stock remained 2.19 million shares. The beta of the stock remained 2.41. Rentech, Inc. (Rentech) is a provider of clean energy solutions. The Company owns and operates a nitrogen fertilizer plant in East Dubuque, Illinois, that manufactures and sells natural gas-based nitrogen fertilizer products within the corn-belt region in the United States. It is developing energy projects to produce certified synthetic fuels and electric power from carbon-containing materials, such as biomass, waste and fossil resources. Its technologies can produce synthesis gas (syngas) from biomass and waste materials, and convert syngas from its own or other gasification technologies into complex hydrocarbons (the Rentech Process) that are then upgraded into fuels using refining technology that it licenses.
Will RTK Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)